BNP Paribas vs Pfizer: Founders, CEOs and History
BNP Paribas was founded in 2000 by Michel Pébereau, Louis-Raphaël Bischoffsheim, Laurent-Antoine Pagnerre and is led by Jean-Laurent Bonnafé. Pfizer was founded in 1849 by Charles Pfizer, Charles Erhart and is led by Albert Bourla.
Company facts
BNP Paribas
- Founded
- 2000
- Headquarters
- Paris, France
- Current CEO
- Jean-Laurent Bonnafé
- Employees
- 180,000
Pfizer
- Founded
- 1849
- Headquarters
- New York, New York
- Current CEO
- Albert Bourla
- Employees
- 75,000
Founders
BNP Paribas
Michel Pébereau
Pébereau became chairman and chief executive of BNP in 1993 and steered its privatisation that October. In 1999, after Société Générale bid for Paribas, he launched BNP's competing offers for both banks.
Louis-Raphaël Bischoffsheim
Bischoffsheim founded a private bank in Amsterdam in the early 1820s, opened Bischoffsheim, Goldschmidt & Cie in Paris in 1846 and in London in 1860, and in 1863 merged these houses into the Nederlandsche Credit- en Deposito Bank in Amsterdam.
Laurent-Antoine Pagnerre
After the 1847 economic crisis and the February Revolution of 1848 froze credit in Paris, the provisional government created discount banks by decree in March 1848.
Pfizer
Charles Pfizer
Pfizer possesses a historic, immigrant founding story, rooted entirely in the rapid industrial expansion of 19th-century Brooklyn and defined by an effective, intensely meticulous German chemist and his ambitious confectioner cousin.
Charles Erhart
Charles Erhart's role in Pfizer's founding is less celebrated than his cousin's, partly because the company carries Charles Pfizer's name and partly because his commercial contributions were less visible than the scientific achievements that drove the company'…
CEOs and their tenures
BNP Paribas
- Michel Pébereau2000–2003
Chairman and Chief Executive Officer
As the legendary architect of the modern bank, he served as CEO and Chairman for decades, transforming a privatized domestic French bank into a massive global institution.
Source - Baudouin Prot2003–2011
Chief Executive Officer
As CEO, he navigated the bank through the global financial crash without requiring a direct French government bailout, heavily expanding its retail footprint across Italy and Belgium.
Source - Jean-Laurent Bonnafé2011–present
Chief Executive Officer
Bonnafé, a graduate of École Polytechnique and the Corps des mines who joined BNP in 1993, ran BNP Paribas Fortis after the 2009 takeover and became group CEO on 1 December 2011.
Source
Pfizer
- Ian Read2010–2018
Chief Executive Officer
He ruthlessly cut R&D spending and eliminated tens of thousands of jobs, significantly boosting short-term earnings per share despite massive patent cliffs for blockbuster drugs like Lipitor.
Source - Albert Bourla2019–present
Chairman and Chief Executive Officer
A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
Source - Dave Denton2022–2026
Chief Financial Officer
As CFO, he aggressively restructured the balance sheet following the Seagen acquisition, prioritizing debt reduction while defending the dividend.
Source - Chris Boshoff2025–present
Chief Scientific Officer and President, Research & Development
He completely restructured the research and development organization to focus on antibody-drug conjugates (ADCs), aggressively expanding Pfizer's pipeline of cancer therapeutics.
Source - Cecile Guegan2026–present
Interim Chief Financial Officer
She modernized the company's internal auditing and compliance structures, ensuring rapid but safe clinical execution for high-priority vaccine programs.
Source
Timeline: BNP Paribas and Pfizer side by side
1848BNP Paribas
Comptoir national d'escompte de Paris founded
Created by decree in March 1848 to restart commercial credit after the February Revolution, with capital from private subscribers, the City of Paris and the State. It is the oldest root of the BNP side of the group.
1849Pfizer
Pfizer Founded
Charles Pfizer and Charles Erhart founded the company in Brooklyn.
1860BNP Paribas
First overseas branches in Shanghai and Calcutta
The Comptoir opened branches in Shanghai and Calcutta, becoming the first French bank to build a branch network abroad from scratch, later adding Hong Kong, London, San Francisco and Sydney.
1872BNP Paribas
Banque de Paris et des Pays-Bas formed
The Banque de Paris, founded in 1869, merged on 27 January 1872 with Louis-Raphaël Bischoffsheim's Amsterdam-based Nederlandsche Credit- en Deposito Bank to create the investment bank later known as Paribas.
1889BNP Paribas
Comptoir rescued after the copper crash
Losses on industrialist Eugène Secrétan's attempt to corner the copper market forced the Comptoir d'escompte de Paris into liquidation, backed by a 100-million-franc Banque de France advance. It was refounded in June 1889 as a deposit bank.
1944Pfizer
Penicillin Scale-Up
Pfizer helped industrialize penicillin production during World War II.
1966BNP Paribas
Banque Nationale de Paris created
Finance minister Michel Debré merged the state-owned CNEP and Banque nationale pour le commerce et l'industrie (BNCI) to form Banque Nationale de Paris (BNP).
1982BNP Paribas
Paribas nationalised
The Mauroy government nationalised Paribas, which adopted its telegraph address, Paribas, as its brand that year.
1987BNP Paribas
Paribas privatised
The Chirac government returned Paribas to private ownership in January 1987.
1993BNP Paribas
BNP privatised
BNP was privatised in October 1993 under chairman Michel Pébereau.
1998Pfizer
Viagra Approved
The FDA approved Viagra in 1998.
1999BNP Paribas
Three-way takeover battle
Société Générale bid for Paribas, and BNP answered with offers for both banks. BNP won control of Paribas but failed to take Société Générale.
2000BNP Paribas
BNP Paribas created
The merger of BNP and Paribas was completed in May 2000, combining BNP's retail network with Paribas's investment banking.
2000Pfizer
Warner-Lambert Deal
Pfizer acquired Warner-Lambert, adding Lipitor.
2001BNP Paribas
Full ownership of BancWest
BNP Paribas agreed to buy the 55% of BancWest, parent of Bank of the West and First Hawaiian Bank, that it did not already own for about $2.45 billion. The Federal Reserve approved the deal on 4 December 2001.
2006BNP Paribas
BNL acquired in Italy
BNP Paribas bought Banca Nazionale del Lavoro, making Italy its second domestic retail market.
2009BNP Paribas
Fortis Bank acquired in Belgium
In May 2009 BNP Paribas took control of Fortis Bank, now BNP Paribas Fortis, paying with new shares issued to the Belgian state and the Grand Duchy of Luxembourg. It also bought 25% of AG Insurance for ~$1.55 billion (€1.375 billion).
2014BNP Paribas
US sanctions guilty plea
BNP Paribas pleaded guilty in New York and agreed to pay about $8.9 billion for processing dollar transactions for Sudan, Iran and Cuba in breach of US sanctions.
2019Pfizer
Albert Bourla becomes CEO
Albert Bourla became CEO of Pfizer in 2019. A veterinarian by training who joined Pfizer Animal Health in 1993, Bourla became CEO on January 1, 2019 and Chairman in 2020.
2020Pfizer
BioNTech COVID Vaccine Partnership
Pfizer and BioNTech brought Comirnaty through emergency authorization.
2023BNP Paribas
Bank of the West sold to BMO
BNP Paribas completed the $16.3 billion cash sale of Bank of the West to BMO Financial Group on 1 February 2023, leaving US retail banking.
2023Pfizer
Seagen Acquisition
Pfizer completed the $43 billion Seagen acquisition.
2025BNP Paribas
AXA Investment Managers acquired
BNP Paribas Cardif completed the ~$5.76 billion (€5.1 billion) purchase of AXA IM on 1 July 2025 and signed a long-term partnership to manage a large part of AXA's assets.
2025BNP Paribas
Sudan jury verdict
A Manhattan federal jury found BNP Paribas liable to three Sudanese refugees in October 2025 and awarded $20.75 million. The bank is appealing.
2025Pfizer
Chris Boshoff Becomes CSO
Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
2025Pfizer
Metsera Acquisition
Pfizer completed its acquisition of obesity drug developer Metsera in November 2025 for up to about $10 billion including CVRs.
2025Pfizer
FY2025 Revenue Base
Pfizer reported $62.579 billion of FY2025 revenue.
2026BNP Paribas
Ageas partnership reset
On 28 April 2026 BNP Paribas Fortis sold its 25% of AG Insurance to Ageas for ~$2.15 billion (€1.9 billion) and renewed their Belgian bancassurance partnership, while Cardif raised its Ageas stake to 22.5%.
2026BNP Paribas
Arval completes Athlon purchase
Arval completed its purchase of Athlon from Mercedes-Benz Group on 31 July 2026, reaching a combined fleet of 2.3 million vehicles.
2026Pfizer
Innovent Oncology Collaboration
Pfizer signed a 12-program cancer collaboration with Innovent Biologics: $650 million upfront and up to $9.85 billion in milestones.
Acquisitions
BNP Paribas
- Athlon2026Undisclosed
- Additional stake in Ageas2026~$1.2B
- AXA Investment Managers2025~$5.8B
- Nickel (Compte-Nickel)2017Undisclosed
- Fortis Bank (now BNP Paribas Fortis)2009Undisclosed
- Banca Nazionale del Lavoro (BNL)2006~$10.2B
Pfizer
- Metsera, Inc.2025$7B
- Seagen Inc.2023$43B
- Medivation Inc.2016$14B
- Wyeth2009$68B
- Pharmacia Corporation2003$60B
- Warner-Lambert Company2000$111B
Questions about BNP Paribas vs Pfizer
Who is the CEO of BNP Paribas SA and Pfizer Inc.?
BNP Paribas SA is led by Jean-Laurent Bonnafé and Pfizer Inc. is led by Albert Bourla. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was BNP Paribas SA founded vs Pfizer Inc.?
Pfizer Inc. was founded in 1849 — 151 years before BNP Paribas SA, which was founded in 2000. Pfizer Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger BNP Paribas SA.
How many employees does BNP Paribas SA have compared to Pfizer Inc.?
BNP Paribas SA employs approximately 180,000 people, while Pfizer Inc. employs approximately 75,000. BNP Paribas SA has the larger workforce at 180,000 employees, compared to Pfizer Inc.'s 75,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are BNP Paribas SA and Pfizer Inc. headquartered?
BNP Paribas SA is headquartered in France and Pfizer Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded BNP Paribas SA and Pfizer Inc.?
BNP Paribas SA was founded by Michel Pébereau, Louis-Raphaël Bischoffsheim, Laurent-Antoine Pagnerre. Pfizer Inc. was founded by Charles Pfizer, Charles Erhart.
Which company has a longer operating history — BNP Paribas SA or Pfizer Inc.?
Pfizer Inc. has been operating for approximately 177 years, making it the more established of the two companies. BNP Paribas SA has been in operation for around 26 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the BNP Paribas vs Pfizer overview